SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10443	Companies
219242	Keywords
148699	Articles
115971	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/19/2025 at 20:21, 5 months 3 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 5 months 6 days ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF

published on 12/17/2025 at 07:35, 5 months 6 days ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
PRESS RELEASE

published on 12/17/2025 at 07:30, 5 months 6 days ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 5 months 8 days ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 5 months 8 days ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
PRESS RELEASE

published on 12/15/2025 at 07:05, 5 months 8 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 5 months 8 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 5 months 8 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 5 months 12 days ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi

Accesswire

Published on 05/23/2026 at 03:15, 16 hours 20 minutes ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 16 hours 35 minutes ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 17 hours 10 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 17 hours 10 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 18 hours 35 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

View all ACCESSWIRE

EQS Group

Published on 05/23/2026 at 16:30, 3 hours 4 minutes ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 3 hours 37 minutes ago

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 21 hours 29 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 23 hours 43 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 1 day 1 hour ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring

Les Echos

Published on 05/22/2026 at 18:05, 1 day 1 hour ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 6 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 1 day 11 hours ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 2 days 1 hour ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 2 days 1 hour ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE